BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31439233)

  • 1. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
    Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
    Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population.
    Barrett T; McLean M; Priest AN; Lawrence EM; Patterson AJ; Koo BC; Patterson I; Warren AY; Doble A; Gnanapragasam VJ; Kastner C; Gallagher FA
    Eur Radiol; 2018 Aug; 28(8):3141-3150. PubMed ID: 29222677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mono-exponential, bi-exponential, kurtosis, and fractional-order calculus models of diffusion-weighted imaging in characterizing prostate lesions in transition zone.
    Liu G; Lu Y; Dai Y; Xue K; Yi Y; Xu J; Wu D; Wu G
    Abdom Radiol (NY); 2021 Jun; 46(6):2740-2750. PubMed ID: 33388809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
    Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
    J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
    Shan Y; Chen X; Liu K; Zeng M; Zhou J
    Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
    Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
    Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
    AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
    Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
    Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer.
    Wang Q; Li H; Yan X; Wu CJ; Liu XS; Shi HB; Zhang YD
    Urol Oncol; 2015 Aug; 33(8):337.e15-24. PubMed ID: 26048104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion kurtosis imaging study of prostate cancer: preliminary findings.
    Tamura C; Shinmoto H; Soga S; Okamura T; Sato H; Okuaki T; Pang Y; Kosuda S; Kaji T
    J Magn Reson Imaging; 2014 Sep; 40(3):723-9. PubMed ID: 24924835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer].
    Wen R; Zhao WL; Wei CG; Gu YF; Li MJ; Zhang YY; Shen JK
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):823-828. PubMed ID: 30893724
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of fitting models for prostate tissue characterization using extended-range b-factor diffusion-weighted imaging.
    Langkilde F; Kobus T; Fedorov A; Dunne R; Tempany C; Mulkern RV; Maier SE
    Magn Reson Med; 2018 Apr; 79(4):2346-2358. PubMed ID: 28718517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.
    Zhang K; Shen Y; Zhang X; Ma L; Wang H; An N; Guo A; Ye H
    PLoS One; 2016; 11(3):e0151176. PubMed ID: 26963936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.